Domenico Girelli: Continuing Commitment to Rare Disease Research
Domenico Girelli, Full Professor of Internal Medicine at the University of Verona, Director of the Department of Medicine at the University of Verona, and Director of the Internal and Emergency Unit at the University Hospital of Verona, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our commitment to research in rare diseases continues…”
Title: Dapagliflozin in Patients With CKD With Fabry Disease
Authors: Yuri Battaglia, Nicola Vitturi, Giacomo Marchi, Federica Baciga, Federica Caccia, Giorgia Gugelmo, Loris Martinetti, Lucia Federica Stefanelli, Sara Torresani, Antonio Pisani, Eleonora Riccio, Pasquale Esposito, Francesca Viazzi, Cristina Chimenti, Francesca Katiana Martino, Livia Lenzini, Annalisa Sechi, Luca Zanoli, Domenico Girelli, Gian Paolo Fadini, Gianni Carraro
Read the Full Article on Science Direct․
Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly